Skip to main content

Table 1 Production details from the PET-centers in Trondheim and Tromsø

From: Stability evaluation of [18F]FDG: literature study, stability studies from two different PET centres and future recommendations

Production details Batch
FDG191211015 (Trondheim) FDG191212016 (Trondheim) FDG200114004 (Trondheim) FDG210824 (Tromsø) FDG210901 (Tromsø) FDG211012 (Tromsø)
EOB activity (GBq) 160 160 160 175 176 178
Mean target current 47.42 48.8 46.86 41.37 44.96 50.64
Timepoint EOS 07:29:37 07:28:30 07:28:45 07:24:06 07:25:27 07:23:53
Timepoint bulk measurement 07:47:32 07:38:28 07:35:10 07:30:14 07:31:41 07:29:45
Activity in bulk (GBq) 96.06 103,586 99.47 117.14 120.37 108.49
Volume bulk (mL) 19.33 20,33 22.29 21.79 21.49 21.28
Concentration in bulk at EOS (GBq/mL), pre-dilution 5.56 5,43 4,65 5.59 5.83 5.29
Timepoint measured patient vial 08:13:08 08:08:07 08:25:37 07:54:41 07:58:23 07:52:58
Activity patient vial (GBq) 37.09 40.3 36.52 37.21 36.82 38.38
Volume patient vial (mL) 11.7 12.32 12.46 10,7 10,14 10,09
Concentration patient vial at EOS (GBq/mL) 4.17 4.20 4.20 4.22 4.47 4.57
Concentration patient vial at dispensing (GBq/mL) 3.17 3.27 2.93 3.48 3.63 3.80
  1. Pre-dilution is fixed at 1mL